QIAGEN powered by

Target discovery through QIAGEN IPA and HSMD – May. 3

Date: 2022/05/03 Duration: 01:30:00 Presented by:

This webinar will focus on using QIAGEN IPA and HSMD to identify key regulators in ‘omic data and study the genomic characteristics and landscape of both target and disease.

Identifying and studying the genomic characteristics of drug targets and important genes are of great interest to many researchers as it can offer new insights into improving drug discovery and precision medicine. In this 90-minute training, QIAGEN Human Somatic Mutation Database (HSMD) will be introduced for genomic investigation. HSMD is a web-based database containing data for hundreds of thousands of variants within the context of solid tumors and hematological malignancies. Specifically, HSMD provides gene-level, alteration-level, and disease-level information including clinically observed gene and variant frequencies across diseases.

Attendees will learn how to:
• Use IPA to identify key regulators within a dataset of interest
• Use HSMD to investigate variants for target genes and diseases of interest
• Synthesize key findings from drug labels, clinical trials, and PubMed articles for specific alterations and diseases

Click here to register.